Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Total Liabilities (Quarterly): 183.24M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 183.24M |
| June 30, 2023 | 186.09M |
| March 31, 2023 | 171.13M |
| December 31, 2022 | 206.13M |
| September 30, 2022 | 174.03M |
| June 30, 2022 | 167.79M |
| March 31, 2022 | 172.02M |
| December 31, 2021 | 191.72M |
| September 30, 2021 | 169.40M |
| June 30, 2021 | 226.78M |
| March 31, 2021 | 121.42M |
| December 31, 2020 | 115.34M |
| September 30, 2020 | 68.91M |
| June 30, 2020 | 58.95M |
| March 31, 2020 | 57.22M |
| December 31, 2019 | 49.90M |
| September 30, 2019 | 36.21M |
| June 30, 2019 | 28.98M |
| March 31, 2019 | 25.81M |
| December 31, 2018 | 26.88M |
| September 30, 2018 | 22.60M |
| June 30, 2018 | 18.84M |
| March 31, 2018 | 16.70M |
| December 31, 2017 | 13.96M |
| September 30, 2017 | 13.91M |
| Date | Value |
|---|---|
| June 30, 2017 | 12.02M |
| March 31, 2017 | 11.65M |
| December 31, 2016 | 15.14M |
| September 30, 2016 | 13.67M |
| June 30, 2016 | 13.81M |
| March 31, 2016 | 10.85M |
| December 31, 2015 | 9.841M |
| September 30, 2015 | 9.821M |
| June 30, 2015 | 7.154M |
| March 31, 2015 | 5.131M |
| December 31, 2014 | 5.417M |
| September 30, 2014 | 5.571M |
| June 30, 2014 | 44.84M |
| March 31, 2014 | 42.72M |
| December 31, 2013 | 38.65M |
| September 30, 2013 | 41.56M |
| June 30, 2013 | 16.80M |
| March 31, 2013 | 5.834M |
| December 31, 2012 | 5.385M |
| September 30, 2012 | 4.982M |
| June 30, 2012 | 3.457M |
| March 31, 2012 | 2.797M |
| December 31, 2011 | 3.761M |
| September 30, 2011 | 3.584M |
| June 30, 2011 | 4.832M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
49.90M
Minimum
Dec 2019
226.78M
Maximum
Jun 2021
145.00M
Average
170.27M
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 76.47B |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
| Puma Biotechnology Inc | 156.49M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.130B |
| Shareholders Equity (Quarterly) | 946.46M |
| Current Ratio | 7.542 |